The most significant effect observed is with the change from baseline results .
Some evidence suggests post-intervention and change from baseline systolic blood pressure improvement at the nine to twelve month interval and change from baseline improvement at the 4 year timeframe .
There is no evidence that group visits improve LDL cholesterol values of the group visit participants .
IMPLICATION S FOR PRACTICE The evidence suggests that the most powerful model of Group medical visits ( GMV ) is when a clinician prescriber is present during or immediately after GMV sessions for medication reconciliation or individual patient needs .
BACKGROUND The prevalence of diabetes mellitus is ubiquitous .
Complications and costs of diabetes are rising and are depleting limited re sources .
It is imperative for healthcare professionals and patients alike to confront this chronic condition by exploring new interventions .
An innovative health care delivery model has emerged in the last 25 years in the form of the group medical visit .
Group medical visits can range from of six to twenty patients scheduled together with time allotted for individual care as well as in the group setting .
Can a Chronic Care Model Collaborative Reduce Heart Disease Risk in Patients with Diabetes?
Background There is a need to identify effective practical interventions to decrease cardiovascular disease risk in patients with diabetes . Objective We examine the impact of participation in a collaborative implementing the chronic care model ( CCM ) on the reduction of cardiovascular disease risk in patients with diabetes . Design Controlled pre- and postintervention study . Patients / Participants Persons with diabetes receiving care at 13 health care organizations exposed to the CCM collaborative and controls receiving care in nonexposed sites . Measurements and Main Results Ten-year risk of cardiovascular disease ; determined using a modified United Kingdom Prospect i ve Diabetes Study risk engine score . A total number of 613 patients from CCM intervention sites and 557 patients from usual care control sites met the inclusion criteria . The baseline mean 10-year risk of cardiovascular disease was 31 % for both the intervention group and the control group . Participants in both groups had improved blood pressure , lipid levels , and HbA1c levels during the observation period . R and om intercept hierarchical regression models showed that the intervention group had a 2.1 % ( 95 % CI −3.7 % , −0.5 % ) greater reduction in predicted risk for future cardiovascular events when compared to the control group . This would result in a reduced risk of one cardiovascular disease event for every 48 patients exposed to the intervention . Conclusions Over a 1-year interval , this collaborative intervention using the CCM lowered the cardiovascular disease risk factors of patients with diabetes who were cared for in the participating organization ’s setting s. Further work could enhance the impact of this promising multifactorial intervention on cardiovascular disease risk reduction
The most significant effect observed is with the change from baseline results .
Some evidence suggests post-intervention and change from baseline systolic blood pressure improvement at the nine to twelve month interval and change from baseline improvement at the 4 year timeframe .
There is no evidence that group visits improve LDL cholesterol values of the group visit participants .
IMPLICATION S FOR PRACTICE The evidence suggests that the most powerful model of Group medical visits ( GMV ) is when a clinician prescriber is present during or immediately after GMV sessions for medication reconciliation or individual patient needs .
BACKGROUND The prevalence of diabetes mellitus is ubiquitous .
Complications and costs of diabetes are rising and are depleting limited re sources .
It is imperative for healthcare professionals and patients alike to confront this chronic condition by exploring new interventions .
An innovative health care delivery model has emerged in the last 25 years in the form of the group medical visit .
Group medical visits can range from of six to twenty patients scheduled together with time allotted for individual care as well as in the group setting .